Ahmed Nabeel
Known title: Chief Financial OfficerCIK: 0001870610
Associated companies
Transaction History
| OM | ▼ Sell | Open Market | 584 | $10K | 5/15/2025 | View on chart |
| OM | ▼ Sell | Open Market | 8,659 | $8K | 2/18/2025 | View on chart |
| OM | ▼ Sell | Open Market | 907 | $726 | 1/21/2025 | View on chart |
| OM | ▼ Sell | Open Market | 29,474 | $24K | 1/21/2025 | View on chart |
| OM | ▼ Sell | Open Market | 3,907 | $3K | 1/21/2025 | View on chart |
| OM | ▲ Buy | Grant | 13,256 | $0 | 1/17/2025 | View on chart |
| OM | ▼ Sell | Open Market | 29,031 | $24K | 1/13/2025 | View on chart |
| OM | ▼ Sell | Open Market | 1,835 | $2K | 1/7/2025 | View on chart |
| OM | ▼ Sell | Open Market | 4,221 | $3K | 11/15/2024 | View on chart |
| OM | ▼ Sell | Open Market | 3,971 | $3K | 8/15/2024 | View on chart |
| OM | ▼ Sell | Open Market | 3,918 | $14K | 5/16/2024 | View on chart |
| OM | ▼ Sell | Open Market | 1,584 | $5K | 3/1/2024 | View on chart |
| OM | ▼ Sell | Other | 1,584 | $4K | 2/29/2024 | View on chart |
| OM | ▲ Buy | Grant | 20,922 | $0 | 2/23/2024 | View on chart |
| OM | ▼ Sell | Tax Withholding | 10,639 | $40K | 2/23/2024 | View on chart |
| OM | ▼ Sell | Open Market | 4,403 | $16K | 2/15/2024 | View on chart |
| OM | ▼ Sell | Open Market | 1,726 | $7K | 1/16/2024 | View on chart |
| OM | ▲ Buy | Grant | 136,000 | $0 | 1/12/2024 | View on chart |
| OM | ▲ Buy | Grant | 100,000 | $0 | 1/12/2024 | View on chart |
| OM | ▲ Buy | Grant | 5,904 | $0 | 1/12/2024 | View on chart |
| OM | ▼ Sell | Open Market | 10,709 | $59K | 1/8/2024 | View on chart |
| OM | ▼ Sell | Open Market | 1,643 | $8K | 11/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 545 | $7K | 9/1/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,565 | $24K | 8/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 990 | $20K | 8/1/2023 | View on chart |
| OM | ▼ Sell | Open Market | 990 | $21K | 7/3/2023 | View on chart |
| OM | ▼ Sell | Open Market | 990 | $21K | 6/1/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,532 | $31K | 5/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 990 | $20K | 5/3/2023 | View on chart |
| OM | ▼ Sell | Open Market | 269 | $7K | 2/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,167 | $28K | 2/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 123 | $3K | 2/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 4,938 | $138K | 1/27/2023 | View on chart |
| OM | ▲ Buy | Grant | 56,634 | $0 | 1/6/2023 | View on chart |
| OM | ▲ Buy | Grant | 3,185 | $0 | 1/6/2023 | View on chart |
| OM | ▼ Sell | Open Market | 121 | $2K | 11/16/2022 | View on chart |
| OM | ▼ Sell | Open Market | 264 | $5K | 11/16/2022 | View on chart |
| OM | ▼ Sell | Open Market | 87 | $2K | 9/1/2022 | View on chart |
| OM | ▼ Sell | Open Market | 121 | $3K | 8/16/2022 | View on chart |
| OM | ▼ Sell | Open Market | 1,048 | $20K | 8/8/2022 | View on chart |
| OM | ▼ Sell | Open Market | 787 | $13K | 7/19/2022 | View on chart |
| OM | ▼ Sell | Open Market | 120 | $3K | 5/17/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 200 | $2K | 5/2/2022 | View on chart |
| OM | ▼ Sell | Open Market | 200 | $7K | 5/2/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 100 | $948 | 4/1/2022 | View on chart |
| OM | ▼ Sell | Open Market | 100 | $5K | 4/1/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 200 | $2K | 4/1/2022 | View on chart |
| OM | ▼ Sell | Open Market | 200 | $9K | 4/1/2022 | View on chart |
| OM | ▼ Sell | Open Market | 424 | $18K | 3/24/2022 | View on chart |
| OM | ▼ Sell | Open Market | 477 | $20K | 3/9/2022 | View on chart |
| OM | ▲ Buy | Grant | 27,350 | $0 | 1/26/2022 | View on chart |
| OM | ▲ Buy | Grant | 1,538 | $0 | 1/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Hims & Hers news mentioned in broader market context
Recent coverage from Yahoo discusses reasons to retain Hims & Hers stock, which shares the digital health sector with Outset Medical. While the article focuses on a different company, it highlights ongoing investor interest in the broader telehealth and digital medicine space. Outset Medical remains a high-beta stock with significant volatility, as seen in its wide 52-week range.
Hims & Hers news mentioned in broader market context. Recent coverage from Yahoo discusses reasons to retain Hims & Hers stock, which shares the digital health sector with Outset Medical. While the article focuses on a different company, it highlights ongoing investor interest in the broader telehealth and digital medicine space. Outset Medical remains a high-beta stock with significant volatility, as seen in its wide 52-week range.